scispace - formally typeset
W

Wei Feng

Researcher at China Food and Drug Administration

Publications -  5
Citations -  74

Wei Feng is an academic researcher from China Food and Drug Administration. The author has contributed to research in topics: Chemistry & Medicine. The author has an hindex of 3, co-authored 3 publications receiving 50 citations.

Papers
More filters
Journal ArticleDOI

Analysis of prenylflavonoids from aerial parts of Epimedium grandiflorum and dietary supplements using HPTLC, UHPLC-PDA and UHPLC-QToF along with chemometric tools to differentiate Epimedium species.

TL;DR: An UHPLC method was developed for the determination of 15 prenylflavonoids from aerial parts of Epimedium grandiflorum and related species (Berberidaceae) and validated for linearity, limits of detection (LOD) and limits of quantification (LOQ), stability and repeatability.
Journal ArticleDOI

The Therapeutic Effect of Coriolus versicolor Fruiting Body on STZ-Induced ICR Diabetic Mice

TL;DR: The results showed that CVFB can control or reduce the fasting blood glucose of mice and accelerate the rate of glucose metabolism, can reduce the levels of total cholesterol, triglyceride, and high-density lipoprotein cholesterol in mice, and regulate the abnormal symptoms of blood lipid metabolism commonly found in diabetes.
Journal ArticleDOI

An excipient-free “sugar-coated bullet” for the targeted treatment of orthotopic hepatocellular carcinoma

TL;DR: Several components of traditional nanoformulations that result in structural heterogeneity, poor reproducibility, excipient-trigged biotoxicity, and low retention of antitumor drugs in neoplastic foci are important barriers limiting clinical translation.